通过JAK-STAT3途径向致病性Th17.1细胞:使用托法西提尼布治疗耐火性脑筋疲劳症的新方法
Rui Zhao1, Chong Yan1, Huahua Zhong1
1Huashan Rare Disease Center and Department of Neurology, Huashan Hospital, Shanghai Medical College, National Center for Neurological Disorders, Fudan University, Shanghai 200040, China.
概括
托法西替尼有效地通过向JAK-STAT通路来治疗耐火性骨髓灰质炎 (MG). 这种Janus激酶抑制剂可以减少类固醇依赖,并改善MG患者的临床结果.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨髓灰质炎 (MG) 在对现有治疗不耐药的患者中存在重大未满足的治疗需求.
- 简氏激酶和信号转换器和转录激活器 (JAK-STAT) 途径对于免疫平衡至关重要,但其在MG病变发生中的作用需要进一步阐明.
- 初步发现表明JAK-STAT信号参与MG.
研究的目的:
- 为了研究泛-JAK抑制剂托法西提尼布在耐火性骨髓灰质炎患者的临床疗效.
- 在MG的背景下探索托法西提尼布的免疫调节机制.
主要方法:
- 一项为期24周的研究 (NCT04431895) 涉及19名耐火性MG患者.
- 托法西提尼布的使用和临床结果的评估,包括葡萄糖皮质醇剂量和MG特异性得分.
- 通过测量p-STAT3,IL-6,IL-23和致病Th17.1细胞水平来分析免疫调节作用.
主要成果:
- 托法西替尼在耐火性MG患者中显著降低了所需的葡萄糖皮质激素剂量.
- 用托法西提尼布治疗的患者在MG相关的临床评分和生活质量方面有所改善.
- 免疫调节作用包括降低p-STAT3,IL-6和IL-23的调节,从而抑制致病性Th17.1细胞.
结论:
- 托法西替尼 (tofacitinib) 证明了作为一种新型治疗选择的疗效和耐受性,用于耐火性严重肌痛性肌痛症.
- 用托法西提尼布向JAK-STAT3信号通路提供了一种有希望的策略,可以抑制MG中的致病性Th17.1细胞.
- 这种方法解决了难以治疗的MG人群中对有效治疗的未满足需求.
相关概念视频
The JAK-STAT Signaling Pathway
12.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.2K
T Cell Types and Functions
2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
495
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
495
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K


